Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01221_DB04572_nanopub.RA7N4oL0IuSamFbJSLdc69wFAx0-2s-vNCE8P7IIG71Js#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01221_DB04572 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01221_DB04572 label "DDI between Ketamine and Thiotepa - Thiotepa, a strong CYP2B6 inhibitor, may decrease the metabolism and clearance of Ketamine, a CYP2B6 substrate. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Ketamine if Thiotepa is initiated, discontinued or dose changed. [drugbank_resource:DB01221_DB04572]" assertion.
- drugbank_resource:DB01221_DB04572 identifier "drugbank_resource:DB01221_DB04572" assertion.
- drugbank_resource:DB01221_DB04572 title "DDI between Ketamine and Thiotepa - Thiotepa, a strong CYP2B6 inhibitor, may decrease the metabolism and clearance of Ketamine, a CYP2B6 substrate. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Ketamine if Thiotepa is initiated, discontinued or dose changed." assertion.
- drugbank:DB04572 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01221_DB04572 assertion.
- drugbank:DB01221 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01221_DB04572 assertion.